Form 4: Clorox EVP Reports Routine Stock Transactions

Clorox EVP Kirsten Marriner reported the acquisition of shares from vested performance units and subsequent dispositions for tax obligations.

Summary

• Kirsten Marriner, EVP Chief Admin Officer of The Clorox Company, reported transactions involving common stock.
• On October 3, 2025, Marriner acquired 9,293 shares of Common Stock at a price of $122.25 per share, stemming from the settlement of a 2022 Performance Unit Grant that vested on the same date.
• Following this acquisition, Marriner's beneficial ownership was 43,421 shares.
• Also on October 3, 2025, Marriner disposed of 1,653 shares of Common Stock at $122.25 per share to satisfy tax obligations related to the vesting of restricted stock.
• After this disposition, beneficial ownership stood at 41,768 shares.
• A further disposition of 3,488 shares of Common Stock at $122.25 per share occurred on October 3, 2025, to cover tax obligations related to the vesting of performance stock units.
• The final reported beneficial ownership after these transactions is 38,280 shares.
• The reported beneficial ownership includes 534 shares acquired through a dividend reinvestment feature of the Company's Stock Incentive Plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reports routine insider transactions related to executive compensation, including vesting and tax withholding, which are expected and do not indicate a significant positive or negative shift in company prospects.

Positives

• The acquisition of 9,293 shares indicates the vesting of a 2022 Performance Unit Grant, reflecting the achievement of performance targets by the executive.

Negatives

• The disposition of 5,141 shares (1,653 + 3,488) was solely for tax withholding purposes, which is a common practice and not indicative of a negative outlook on the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive landscape. It reflects standard executive compensation practices within the consumer staples sector.

Stakeholder Impact

• Shareholders: The transactions represent a routine change in an executive's direct ownership, which is generally not expected to have a material impact on the company's stock price or long-term value.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 details routine insider transactions related to executive compensation, specifically the vesting of performance units and subsequent share dispositions for tax purposes. Such transactions are common and do not typically signal a strong directional view on the company's future performance from the insider. Therefore, it does not provide a basis for a 'buy' or 'sell' recommendation, leading to a 'hold' stance as it's a neutral event.

Keywords

Clorox, CLX, Form 4, Insider Transaction, Executive Compensation, Stock Vesting, Performance Units, Tax Withholding